Lazard Asset Management LLC Cuts Stock Holdings in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI)
Lazard Asset Management LLC decreased its stake in shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free Report) by 7.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 2,567 shares of the biopharmaceutical company’s stock after selling 196 shares during the period. […]
Lazard Asset Management LLC decreased its stake in shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free Report) by 7.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 2,567 shares of the biopharmaceutical company’s stock after selling 196 shares during the period. […]
